Luncheon with the Experts: Jaydira Del Rivero, MD

Jaydira Del Rivero, MD, a Physician Scientist in the Developmental Therapeutics Branch of the National Cancer Institute, Center for Cancer Research, ccr.cancer.gov/staff-director..., was the featured guest for Facebook Live Luncheon with the Experts on Thursday, June 30, 2022. Her research is focused on developing novel treatment approaches and targeted therapies for endocrine malignancies including advanced gastroenteropancreatic neuroendocrine tumors, adrenocortical cancer and pheochromocytoma/paraganglioma.
Dr. Del Rivero’s is part of NCI’s Rare Tumor Initiative. For the natural history studies, Dr. Del Rivero’s group collects data about the patients including demographics, clinical characteristics, familial genetics with adequate genetic counseling, patterns of disease progression, response or lack of response to therapeutic interventions, disease recurrence, and overall survival. The goal is to develop novel therapies for these cancers. She is also a national Principal Investigator of the NCI’s National Clinical Trials Network (NCTN) with the Alliance for Clinical Trials in Oncology for a rare type of neuroendocrine tumor.
Dr. Del Rivero is board certified in Internal Medicine, Endocrinology, Diabetes and Metabolism and Oncology. She currently serves on the Board of Directors of the North American Neuroendocrine Tumor Society (NANETS) and is the Guidelines Committee Co-Chair.
CCF’s Luncheon with the Experts series features physicians and healthcare professionals, support group leaders, patients, and colleagues who are key opinion leaders in the neuroendocrine cancer community worldwide. This weekly series is presented via Facebook Live on Thursdays from 12 noon to 1 pm, Eastern Time. Join us for unique discussions on a wide variety of topics for everyone in the NET community!
With special thanks to Ipsen Biopharmaceuticals, sponsor of the Luncheon with the Experts series. “At Ipsen, patients are the heart of our science.”